Change of Adviser

Allergy Therapeutics PLC
14 August 2007


Allergy Therapeutics (the "Company")

CHANGE OF NOMINATED ADVISER AND BROKER

Following completion of the acquisition of Bridgewell Group Plc by Landsbanki
Islands hf, the Company is pleased to announce the appointment of Landsbanki
Securities (UK) Limited as Nominated Adviser and joint Broker with immediate
effect.

For further information please contact:

Allergy Therapeutics Plc
Keith Carter
[phone]

Landsabanki Securities (UK) Limited
Shaun Dobson, Managing Director
Claes Spang, Associate Director
[phone]


                      This information is provided by RNS
            The company news service from the London Stock Exchange